Evidence map›Paper›PMID 26035247›Full record

ReviewNutrients2015

Modulation of the immune response to respiratory viruses by vitamin D.

Claire L Greiller, Adrian R Martineau

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04636086 (Vitamin D Supplementation and Covid-19), which is not on this map. Cited by 236 papers, 19 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
236citing papers in PubMed, 19 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04636086 phase4completednot on this mapstarted 2020, after this paper: background citation

Vitamin D Supplementation and Covid-19: a Randomised, Double- Blind, Controlled Study

TypeinterventionalSponsorUniversity of LiegeRan2020 to 2022Enrolled50ConditionsCovid19ArmsCholecalciferol, Placebo
3 · Its place in the literature

Who cites it

236 citing papers in PubMed, 19 syntheses or guidelines pooled it, 486 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Vitamin D for the management of chronic obstructive pulmonary disease.The Cochrane database of systematic reviews · 2024
    Pooled it
  6. Pooled it
  7. Vitamin D for the management of asthma.The Cochrane database of systematic reviews · 2023
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Trial

176 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Claire L GreillerBarts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AB, UK. c.l.greiller@qmul.ac.uk.
Adrian R MartineauBarts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AB, UK. a.martineau@qmul.ac.uk.
Queen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVitamin D deficiency has been shown to be independently associated with increased risk of viral acute respiratory infection (ARI) in a number of observational studies, and meta-analysis of clinical trials of vitamin D supplementation for prevention of ARI has demonstrated protective effects. Several cellular studies have investigated the effects of vitamin D metabolites on immune responses to respiratory viruses, but syntheses of these reports are lacking. SCOPE: In this article, we review the literature reporting results of in vitro experiments investigating immunomodulatory actions of vitamin D metabolites in human respiratory epithelial cells infected with respiratory viruses. KEY

findingsVitamin D metabolites do not consistently influence replication or clearance of rhinovirus, respiratory syncytial virus (RSV) or influenza A virus in human respiratory epithelial cell culture, although they do modulate expression and secretion of type 1 interferon, chemokines including CXCL8 and CXCL10 and pro-inflammatory cytokines, such as TNF and IL-6. FUTURE RESEARCH: More studies are needed to clarify the effects of vitamin D metabolites on respiratory virus-induced expression of cell surface markers mediating viral entry and bacterial adhesion to respiratory epithelial cells.

Indexed as

ImmunomodulationChemokine CXCL10Dietary SupplementsEpithelial CellsHumansImmunity, InnateInfluenza A virusInterleukin-6Interleukin-8Respiratory Syncytial VirusesRespiratory Tract InfectionsRhinovirusTumor Necrosis FactorsVirus DiseasesVitamin DVitamin D DeficiencyChemokine CXCL10CXCL10 protein, humanCXCL8 protein, humanInterleukin-6Interleukin-8Tumor Necrosis FactorsVitamin Dantiviral immunityrespiratory virusesvitamin D

Identifiers

PMID26035247
PMCPMC4488782
OpenAlexW2137836062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.